Abstract
We identified a non-peptidomimetic HIV protease inhibitor sanguinarine through screening a small compound library with a high-throughput E. coli-based assay. In vitro, sanguinarine inhibits the HIV protease with an IC50 of around 13 μM. Based on docking results, binding modes of sanguinarine to the HIV protease are proposed.
Original language | English (US) |
---|---|
Pages (from-to) | 364-371 |
Number of pages | 8 |
Journal | Letters in Drug Design and Discovery |
Volume | 2 |
Issue number | 5 |
DOIs | |
State | Published - Aug 2005 |
Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Molecular Medicine
- Pharmaceutical Science
- Drug Discovery
Keywords
- E. coli-based system
- HIV protease
- HIV protease inhibitors
- HIV protease precursor
- High-throughput screening
- Sanguinarine